118 related articles for article (PubMed ID: 2424454)
1. Endothelial injury caused by antineoplastic agents.
Lazo JS
Biochem Pharmacol; 1986 Jun; 35(12):1919-23. PubMed ID: 2424454
[TBL] [Abstract][Full Text] [Related]
2. Drug-radiation interactions in tumor blood vessels.
Hallahan DE; Chen AY; Teng M; Cmelak AJ
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):71-7. PubMed ID: 10550829
[TBL] [Abstract][Full Text] [Related]
3. Vascular attack as a therapeutic strategy for cancer.
Denekamp J
Cancer Metastasis Rev; 1990 Nov; 9(3):267-82. PubMed ID: 2292139
[TBL] [Abstract][Full Text] [Related]
4. The vascular endothelial system. Structure--function--pathology--reaction to endotoxin shock--methods of investigation.
Freudenberg N; Riese KH; Freudenberg MA
Veroff Pathol; 1983; 120():1-114. PubMed ID: 6858380
[No Abstract] [Full Text] [Related]
5. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy and endothelial cell targeting for cancer.
Evans RR; Calmels TP; Pitt BR; Brookens MA; Johnson CS; Modzelewski RA; Lazo JS
Ann N Y Acad Sci; 1994 May; 716():257-64. PubMed ID: 7517652
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary toxicity of antineoplastic agents--with special reference to current findings on pulmonary toxicity of bleomycin].
Okuma K; Ota K
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1495-505. PubMed ID: 6191717
[TBL] [Abstract][Full Text] [Related]
8. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
[TBL] [Abstract][Full Text] [Related]
9. [Endothelial cell-cell junctions in vessel formation].
Huber P
J Soc Biol; 2009; 203(2):119-23. PubMed ID: 19527625
[TBL] [Abstract][Full Text] [Related]
10. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions.
Nagy Z; Peters H; Hüttner I
Lab Invest; 1984 Mar; 50(3):313-22. PubMed ID: 6422163
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyclophosphamide on the rat's mesenteric lymph node.
Loc NK; Oláh I; Kittner Z; Takács L; Törö I
Acta Morphol Acad Sci Hung; 1981; 29(4):335-51. PubMed ID: 7340423
[TBL] [Abstract][Full Text] [Related]
12. Vascular disrupting agents in clinical development.
Hinnen P; Eskens FA
Br J Cancer; 2007 Apr; 96(8):1159-65. PubMed ID: 17375046
[TBL] [Abstract][Full Text] [Related]
13. Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity.
Nicolson GL; Custead SE
Cancer Res; 1985 Jan; 45(1):331-6. PubMed ID: 3965142
[TBL] [Abstract][Full Text] [Related]
14. Cerebral vessels cryofixed after hyperosmosis or cold injury in normothermic and hypothermic frogs.
Nagy Z; Pettigrew KD; Meiselman S; Brightman MW
Brain Res; 1988 Feb; 440(2):315-27. PubMed ID: 3258781
[TBL] [Abstract][Full Text] [Related]
15. Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons.
Lin Y; Paganetti H; McMahon SJ; Schuemann J
Med Phys; 2015 Oct; 42(10):5890-902. PubMed ID: 26429263
[TBL] [Abstract][Full Text] [Related]
16. Taking down tumors: vascular disrupting agents entering clinical trials.
O'Hanlon LH
J Natl Cancer Inst; 2005 Sep; 97(17):1244-5. PubMed ID: 16145041
[No Abstract] [Full Text] [Related]
17. Biomedical aspects of targeted delivery of drugs to pulmonary endothelium.
Muzykantov VR
Expert Opin Drug Deliv; 2005 Sep; 2(5):909-26. PubMed ID: 16296786
[TBL] [Abstract][Full Text] [Related]
18. [Carcinostatics on vascular endothelium (author's transl)].
Ito K
Yonago Acta Med; 1973 Jul; 17(1):25-33. PubMed ID: 4802152
[No Abstract] [Full Text] [Related]
19. Vascular disrupting agents.
Lippert JW
Bioorg Med Chem; 2007 Jan; 15(2):605-15. PubMed ID: 17070061
[TBL] [Abstract][Full Text] [Related]
20. [Cytoskeleton of endothelial cells, its functional significance and technics for studying it].
Karaganov IaL; Mironov VA; Mironov AA; Gusev SA
Arkh Anat Gistol Embriol; 1981 Sep; 81(9):5-26. PubMed ID: 7032474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
